Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5881_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Aim and Scope
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •About the Editors
- •1.1 Introduction
- •1.2.1 Friction
- •1.2.1.3 Friction Under Lubricated Conditions
- •1.7.1 Joint Tribology
- •1.7.2 Skin Tribology
- •1.7.3 Oral Tribology
- •1.8 Summary
- •References
- •2.1 Introduction
- •2.3.1 Fluid Pressurization/Fluid-Film Lubrication
- •2.3.2 Boundary Lubrication
- •2.3.3 Hydrodynamic Lubrication
- •2.3.4 Squeeze-Film Lubrication
- •2.3.5 Synovial Fluid
- •2.3.6 Hydration Lubrication
- •2.5.2 Scaffolds
- •2.5.3 Synthetic Polymer
- •2.5.4 Polyacrylamide
- •2.5.5 PEG Hydrogel
- •2.5.6 PVA Hydrogel
- •2.5.7 Double Network Hydrogel
- •2.5.8 Triple Network Hydrogel
- •2.6.1 Polyacrylamide
- •2.6.2 PEG Hydrogel
- •2.6.3 PVA Hydrogel
- •2.6.4 Double Network Hydrogel
- •2.6.5 Triple Network Hydrogel
- •2.7.1 Mechanical Properties
- •2.7.2 Structural Properties
- •2.8 Conclusion
- •References
- •3.1 Introduction
- •3.3.1 Label-Based Biosensors
- •3.3.2 Label-Free Biosensors
- •3.4 Different Nanobiosensing Techniques
- •3.4.1 Optical Sensing
- •3.4.2 Electrochemical/Electrical Sensing
- •3.4.3 Magnetic Sensing
- •3.4.4 Mass-Based Sensing
- •3.6.2 Neurodegenerative Diseases
- •3.6.3 Infectious Diseases
- •3.6.4 Metabolic Diseases
- •References
- •4.1 Introduction
- •4.2.1 Surface Functionalization
- •4.2.2 Bioconjugation
- •4.3 Synthesis Approach
- •4.3.1 Hydrothermal Method
- •4.3.2 Chemical Vapor Deposition (CVD)
- •4.3.3 Wet Chemical Method
- •4.4 Plasmonic Black Bodies (PBBs)
- •4.4.1 Gold NP (AuNPs)-Based PBB
- •4.4.2 Silver NPs (Ag NPs)-Based PBB
- •4.4.3 Platinum NPs (Pt NPs)-Based PBB
- •4.5 Biomimetic NP
- •4.6 Upconverting NP (UCNP)
- •4.6.1 Synthesis
- •4.7 Inorganic NP
- •4.7.1 Synthesis
- •4.8 Photothermal Therapy (PTT)
- •4.9 Conclusion
- •References
- •5.1 Introduction
- •5.2 Human Skin
- •5.10 Future Scope
- •5.11 Conclusion
- •References
- •6.1 Introduction
- •6.1.1 Class 1
- •6.1.2 Class 2
- •6.1.3 Class 3
- •6.4.1.1 Surface Patterning
- •6.4.1.2 Direct-Write Patterning
- •6.4.1.5 Dip-Pen Nanotechnology
- •6.4.1.7 Composing Using Beams
- •6.4.1.8 Direct Write Photolithography (DWP)
- •6.4.1.9 Light-Beam Lithography Electron
- •6.4.1.10 Focused Ion Beam Lithography
- •6.4.2 Fabrication Techniques
- •6.4.2.4 Non-invasive Glucose Monitoring Devices Technique
- •6.4.2.6 Cost-Effective Electrochemical Voltametric Sensors Techniques
- •6.4.2.7 Three-Dimensional (3D) Printing Techniques
- •6.4.2.8 UV-LED Stereolithography Printer Technique
- •6.4.2.9 4D Printing Techniques
- •6.4.2.10 Advanced Biomedical Techniques Involving Biorobots
- •References
- •7.1 Introduction
- •7.6 Mechanical Biocompatibility Challenges
- •7.7 Poor Bio-Printing Resolution
- •7.9 Limited Biomaterial Selection
- •7.11 Conclusion
- •8.2 Animal Tribology
- •8.2.1 Joint
- •8.2.3 Integumentary Change
- •References
- •8.1 Introduction
- •8.3.1 Nanotribology
- •8.4 Green Tribology
- •8.5 Conclusion
- •References
- •9.1 Introduction
- •9.2 Bio-Tribological Issues
- •9.3.2 Bone Fracture Fixation
- •9.3.4 Cardiovascular Devices
- •9.3.5 Minimal Invasive Surgical Devices
- •References
- •10.1 Introduction
- •10.2.2.1 Structural Integrity
- •10.2.2.2 Controlled Release Properties
- •10.2.2.3 Enhanced Drug Loading Capacity
- •10.2.2.4 Tailored Material Properties
- •10.2.3.1 Biocompatibility
- •10.2.3.3 Mechanical Properties
- •10.2.3.4 Drug Compatibility
- •10.2.3.5 Fabrication Compatibility
- •10.3.1 Matrix Material Properties
- •10.3.4 Biocompatibility Assessment
- •10.3.4.1 In Vitro Cell Culture Studies
- •10.3.4.2 Hemocompatibility Studies
- •10.3.4.3 In Vivo Animal Studies
- •10.3.4.4 Histological Analysis
- •10.3.4.5 Immune Response Evaluation
- •10.3.4.6 Biodegradation Assessment
- •10.4 Surface Engineering Considerations
- •10.4.2.1 Surface Coatings
- •10.4.2.2 Plasma Treatment
- •10.4.2.3 Surface Grafting
- •10.4.2.4 Dip Coating
- •10.4.2.5 Spray Coating System
- •10.4.2.6 Electrotreated Coating
- •10.4.2.9 Microfabrication Techniques
- •10.4.2.10 Surface Roughness Control
- •10.5.1.2 Mechanical Properties
- •10.5.1.3 Surface Characteristics
- •10.5.1.4 Release Kinetics Analysis
- •10.5.1.5 Biological Compatibility
- •10.5.1.7 Other Analyses
- •10.6 Advanced Fabrication Techniques
- •10.8 Conclusion
- •References
- •11.1 Introduction
- •11.2 Shape Memory Alloys (SMA)
- •11.3 Shape Memory Polymers
- •11.3.1 Heat
- •11.3.2 Light
- •11.3.3 Magnetic Field
- •11.4 Shape-Changing Hydrogels
- •11.5 Biomedical Applications
- •11.6 Conclusion
- •References
- •12.1 Introduction
- •12.3 Bioresorbable Orthopedic Implants
- •12.4.1 Polylactides
- •12.4.2 Poly (Ortho Esters)
- •12.4.3 Polyphosphoesters
- •12.4.4 Polyphosphazenes
- •12.4.5 Polycaprolactone
- •12.4.6 Polyurethanes
- •12.4.7 Polycarbonates
- •12.5.1 Compression Molding
- •12.5.2 Transfer Molding
- •12.5.3 Injection Molding
- •12.5.4 Extrusion
- •12.5.5 Blow Molding
- •12.5.6 Calendering Process
- •12.5.7 Fiber Spinning
- •12.5.8 Thermoforming
- •12.5.9 Polymer Foaming
- •12.7 Challenges
- •12.8 Conclusion
- •References
- •13.1 Introduction
- •13.3.1.1 Total Hip Replacement (THR)
- •13.3.2 Resurfacing Hip Replacement (RHR)
- •13.5.1 Adhesive Wear
- •13.5.2 Abrasive Wear
- •13.5.3 Fatigue Wear
- •13.5.4 Corrosion/Oxidative Wear
- •13.5.5 Surface Cracking
- •13.6.1 Metallic Implants
- •13.6.1.1 Stainless Steel
- •13.6.1.2 Co-Cr Alloys
- •13.6.1.3 Ti-Alloy
- •13.6.2 Ceramic Implants
- •13.6.3 Polymer Implants
- •13.6.4 Composite Implants
- •13.6.5.2 Surface Coatings
- •13.7.2.1 Hydrodynamic Lubrication
- •13.7.2.2 Boundary Lubrication
- •13.7.2.3 Elastohydrodynamic Lubrication
- •13.7.3 Biomimetic Lubrication Approaches
- •13.7.3.1 Replicating Natural Lubrication Mechanisms
- •13.7.4.1 Implant Wear
- •13.7.4.3 Synovial Fluid Degradation
- •13.8.1 Hydroxyapatite Coatings
- •13.8.1.1 Bone Integration
- •13.8.1.2 Implant Stability
- •13.8.1.4 Biocompatibility
- •13.8.2 Diamond-Like Carbon Coatings
- •13.8.3 Metal Nitride Coatings
- •13.8.4 Polymeric Coatings
- •13.8.5 Nanocomposite Coatings
- •13.9.1 Pin-on-Disk Testing
- •13.9.2 Hip Joint Simulators
- •13.9.3 Knee Joint Simulators
- •13.9.4 Tribo-Corrosion Testing
- •13.9.5 Wear Debris Analysis Techniques
- •13.9.5.1 Scanning Electron Microscopy (SEM)
- •13.9.5.2 Energy-Dispersive X-Ray Spectroscopy (EDS)
- •13.10.1.1 Tailored Geometries
- •13.10.1.2 Improved Wear Characteristics
- •13.10.1.3 Accelerated Innovation
- •13.10.2.1 Real-Time Wear Monitoring
- •13.10.2.2 Functionality Assessment
- •13.10.2.3 Implant Status Monitoring
- •13.10.2.4 Patient-Centric Healthcare
- •13.10.3.1 Advanced Biomaterials
- •13.10.3.4 Multidisciplinary Approaches
- •13.10.4.1 Wear Data Analysis
- •13.10.4.2 Predictive Wear Patterns
- •13.10.4.3 Early Intervention Strategies
- •13.10.4.4 Personalized Treatment Plans
- •13.11 Conclusion
- •References
- •14.1 Introduction
- •14.2.1 Powder Bed Fusion (PBF)
- •14.2.2 Directed Energy Deposition
- •14.3.1 Extrusion-Based AM
- •14.5 Biomanufacturing
- •14.5.1 Tissue Engineering
- •14.5.2 Organ-on-a-Chip Models
- •14.6 Conclusion
- •References
- •Index

10 Composites forDrug-Eluting Devices: Emerging Biomedical Applications
275
10.4.2.3 Surface Grafting
Surface grafting involves attaching functional groups or polymers onto the surface
of drug-eluting composites. This technique can be utilized to introduce hydrophilic
or hydrophobic moieties, altering the surface energy and modifying interactions
with biological tissues. Surface grafting is valuable for tailoring the release kinetics
of therapeutic agents and improving the overall performance of drug-eluting
devices [154].
10.4.2.4 Dip Coating
Dip coating presents itself as a foundational and easily implementable method for
coating stents with drugs and polymers. Its uncomplicated nature, coupled with the
ability to customize the coating composition, makes it a valuable tool in the arsenal
of techniques available for researchers and clinicians involved in the advancement
of drug-eluting stent technologies. It stands out as a fundamental and straightforward technique in coating applications for drug-eluting stents, notable for its simplicity and minimal equipment requirements. This method involves immersing the
stent in a solution containing typical drugs and/or polymers dissolved in a solvent.
The coated stent is then left to undergo a drying process, facilitated by either air
exposure or the controlled environment of an oven, as depicted in Fig.10.3 [155].
The inherent simplicity of dip coating renders it an accessible and practical choice,
particularly in scenarios where extensive machinery or prolonged processing times
are not feasible.
The versatility of dip coating is evident in the varied combinations of polymers,
drugs, and their concentrations that can be employed during the process. Researchers
have the exibility to tailor the coating composition based on the specic requirements of their study. For instance, a study by Jang etal. utilized dip coating to apply
Fig. 10.3 Schematics of
dip coating [155]

276
A. K. Gupta et al.
curcumin onto stents, offering the option to coat them with either a low or high dose
of the therapeutic agent, all without incorporating any additional polymer. This
adaptability in polymer and drug selection, coupled with the simplicity of the dip
coating technique, contributes to its appeal in the development of drug-eluting
stents [59, 155].
10.4.2.5 Spray Coating System
Spray coating emerges as a valuable technique in the manufacturing of DES, presenting versatility in coating designs and scalability for mass production. Despite
the challenges in evaluating this technology, its role in cardiac research remains
pivotal, contributing to advancements in drug-eluting stent technologies. Spray
coating, encompassing techniques such as ultrasonic atomization, electrodynamic
jetting, and airbrush coating, stands out as a prominent method for the application
of polymer and drug solutions onto stent surfaces. Employing devices that spray
these solutions onto the stent using various solvents ensures a uniform and consistent deposit of drug-release layers. This technique is versatile and allows for higher
variability in coating designs, enhancing the optimization of the release prole. The
system schematic presented in Fig. 10.4 illustrates the spray-coating process,
emphasizing its adaptability and ability to produce a logarithmic release curve. This
curve typically exhibits a burst release, attributed to the initial presence of the drug
at the stent’s boundary layer, followed by a slower, sustained release for long-term
therapeutic effects [156].
Spray-coating techniques play a pivotal role in manufacturing drug-eluting stents
(DES), particularly in cardiac research. The method is known for its straightforwardness in scaling up the production of consistently coated stents in high volumes.
Fig. 10.4 Illustration of spray coating system [156]

10 Composites forDrug-Eluting Devices: Emerging Biomedical Applications
277
However, evaluating this technology poses challenges due to the multitude of variables involved, making broad comparisons between individual designs nearly
impractical [156]. Understanding the mechanism of drug delivery is crucial for
selecting the appropriate drug and achieving a time-ordered release. Polymeric systems serve as efcient drug carriers due to their ability to provide a framework for
controlled drug release and protect the drug from degradation before it exerts its
therapeutic effects. The mechanism of drug release from the polymer substrate can
be categorized into physical and chemical mechanisms. The physical mechanism
involves drug release through permanent polymer layers, dissolution or degradation
of the polymer, permeation pressure, and ion exchange processes. On the other
hand, the chemical mechanism results from the breakage of covalent bonds due to
chemical or enzymatic degradation [7]. The evolution of drug-polymer systems has
transitioned from nonbiodegradable to biodegradable polymers, where the latter has
become a signicant player in drug-eluting systems. The drug diffusion process in
nonbiodegradable polymers was controlled by the concentration gradient. In contrast, biodegradable polymers offer three major release mechanisms based on the
type of polymer: diffusion (for permanent polymers), swelling, and degradation.
These mechanisms highlight the versatility and adaptability of polymeric systems in
achieving controlled and effective drug delivery [157].
10.4.2.6 Electrotreated Coating
Electrotreated coating techniques represent a novel approach in stent technology,
introducing electrical stimulus to assist in the deposition of drugs or polymers onto
stent surfaces. One notable method is electrophoretic deposition (EPD), which
employs an electric eld, either in a dry or salted environment, to attract charged
particles onto the stent surface, forming a drug-release layer. The electrophoretic
deposition (EPD) apparatus, as illustrated in Fig.10.5a, provides insight into the
technique’s application [158]. In electrostatic dry powder deposition (Fig.10.5b),
researchers coated stents with sirolimus-loaded PEVA and PBMA microparticles,
comparing the release proles with a commercially available Cypher stent. This
approach exhibited a burst release of 50% in 3days, surpassing the 35% release of
Fig. 10.5 Illustration of (a) electrophoretic deposition (EPD) [157] and (b) electrostatic dry powder deposition [159]

278
A. K. Gupta et al.
the Cypher stent. Additionally, it achieved a total release of 100% after 25days,
exceeding the Cypher stent’s 85% release [159]. Electrotreated coating techniques,
particularly EPD, offer innovative ways to enhance drug release proles in stents.
However, the safety and efcacy of electrotreated stents remain to be evaluated in
clinical settings. Meanwhile, plasma-treated coatings show promise in strengthening drug-release layers, but further research is needed to validate their effectiveness
in DES applications.
In another study by Liu etal., a DES was designed using multiple techniques.
They deposited N-nitrosomelatonin (NOMela)-loaded PLGA nanoparticles onto SS
316L stents using EPD and then applied dip coating to create a collagen diffusion
barrier [160]. Release proles of hydrophobic and hydrophilic drugs were studied
after immersing the stent in PBS, revealing a burst release of 50–70% in 24hours,
with an additional 20% release between days 2 and 14 [160]. While the integration
of electrical stimulus in stent coating presents an exciting development, the safety
and efcacy of electro treated stents have yet to be evaluated in clinical models,
limited to noninferiority animal models. Moving to plasma-treated coatings,
researchers have recently explored the inclusion of plasma treatments to enhance
chemical bonds in drug-release layers through polymer cross-linking. This technique involves exposing the stent surface to a gaseous plasma beam with varying
exposure times. In a study led by Hagiwara, silicon wafers coated with curcuminloaded PEVA were plasma-treated with argon, oxygen, and nitrogen. Results
showed that highly treated samples released signicantly less drug over time compared to untreated stents, demonstrating the potential of plasma treatments as a
release platform for DES [157].
10.4.2.7 Nanocoating andNanoparticle Incorporation
Nanocoatings and the incorporation of nanoparticles on the surface of drug-eluting
composites offer unique opportunities for enhancing properties. Nanoscale materials can provide specic functionalities, such as improved lubrication or targeted
drug delivery. Nanoparticles can be embedded within coatings or directly into the
composite matrix to impart desired surface characteristics, inuencing wear resistance and drug release [161, 162].
10.4.2.8 Polymer Blending andComposite Formation
Mixing different polymers or composite materials during the fabrication process
can lead to the creation of drug-eluting composites with tailored surface properties.
By blending polymers with complementary characteristics, such as one providing
structural integrity and another offering controlled drug release, researchers can
achieve synergistic effects to enhance overall performance [163].

10 Composites forDrug-Eluting Devices: Emerging Biomedical Applications
10.4.2.9 Microfabrication Techniques
Microfabrication techniques, such as micromolding or photolithography, can be
employed to create micro-patterned surfaces on drug-eluting composites.
Microfabrication enhances surface topography and can be utilized to control drug
release proles. This technique allows for precise engineering of surface features,
inuencing wear and friction properties as well as therapeutic agent release [164].
10.4.2.10 Surface Roughness Control
Controlling the surface roughness of drug-eluting composites can be achieved
through techniques such as mechanical polishing, acid etching, or laser ablation
[165]. Optimizing surface roughness [166] is crucial for inuencing wear resistance, improving tissue integration, and reducing friction during device implantation [167].
10.4.2.11 Incorporation ofSmart Materials
Integrating smart materials, such as shape-memory polymers or materials responsive to external stimuli, into the surface of drug-eluting composites allows for
dynamic adjustments in response to environmental changes. These materials can
enhance adaptability and functionality, improving wear resistance and drug release
control. A combination of these techniques can be employed in a synergistic manner
to enhance the surface properties of drug-eluting composites. Surface engineering
plays a pivotal role in tailoring the tribological properties and drug release characteristics, ultimately contributing to the improved performance and efcacy of these
biomedical devices in various clinical applications [168, 169].
279
10.5 Characterizations ofDrug-Eluting Composite
10.5.1 Methods forCharacterizing Composite Materials
Characterizing drug-eluting composites is essential to understanding their performance, ensuring their safety, and optimizing their efcacy in biomedical applications. Various characterization methods are employed to assess different aspects of
these composites, ranging from their structural integrity to drug release kinetics.
The following discusses various methods used to characterize the properties of
drug-eluting composites, as mentioned in Table10.5.
Comprehensive characterization methods are essential to thoroughly understand
the structural, chemical, mechanical, and biological aspects of these composite

280
A. K. Gupta et al.
[174]
Additional insights (from your
data) References
Composite porosity affects drug
Pore size, distribution of
[175]
loading and release rate.
FTIR spectra can identify
therapeutic agents, matrix
homogeneity
Molecular interactions,
[176]
potential drug-matrix
incompatibilities.
Stiffness can affect drug release
kinetics.
potential degradation
products
Suitability for specic
applications, impact
[177]
Wettability inuences cell
resistance
[178]
adhesion and drug diffusion.
Release kinetics need to be
tailored for specic therapeutic
biological uids and
tissues
Release rate prole, drug
stability within the
[179]
goals.
Biocompatibility is crucial for
composite
[180]
long-term implant success.
Imaging can reveal unexpected
potential inammatory
response
Drug targeting, implant
off-target effects.
degradation invivo
[181]
Histology can differentiate
Biomaterial integration,
between sterile and foreign body
reactions.
tissue healing around the
implant
Surface morphology
and microstructure
Functional groups in
matrix and agents
Strength, stiffness,
elasticity
Wettability Interaction with
microscope (SEM)
Fourier transform
infrared spectroscopy
(FTIR)
Tensile, compression,
exural tests
Contact angle
composition analysis
Sr.
no. Properties Technique Focus Information gained
Table 10.5 Methods for characterizing composite materials for characterizations of drug-eluting composites
1 Structural analysis Scanning electron
2 Chemical
properties
3 Mechanical
4 Surface
Quantication of
released drugs
measurement
High-performance liquid
chromatography (HPLC)
Cell viability assays Cytotoxicity Impact on cell health,
characteristics
analysis
5 Release kinetics
6 Biological
persistence of
compatibility
7 In vivo imaging MRI, PET Distribution and
composites
Tissue compatibility,
inammatory response
Histopathological
analysis
response assessment
8 Inammatory

10 Composites forDrug-Eluting Devices: Emerging Biomedical Applications
281
[174, 176]
Stability studies inform storage
and handling guidelines.
– [59]
Shelf life, drug efcacy
within the composite
Swelling can affect drug
[182]
Electrochemical properties
release and device
functionality.
Biomaterial degradation,
[183]
inuence long-term safety and
efcacy.
Thermal stability ensures device
impact on surrounding
tissues
Glass transition
integrity during sterilization and
temperature, drug release
implantation.
behavior
time
Material response to
physiological
conditions
Stability studies Drug degradation over
Weight and size changes,
matrix integrity
analysis
studies
9 Drug stability
10 Swelling and erosion
tissue interaction
EIS Corrosion resistance,
analysis
11 Electrochemical
response to
temperature changes
12 Thermal analysis DSC, TGA Thermal stability,

282
A. K. Gupta et al.
materials. In the context of drug-eluting composites, where the integration of drugs
or therapeutic agents within a matrix is crucial, precise structural analysis becomes
imperative. Techniques such as scanning electron microscopy (SEM) [170] enable
researchers to examine the surface morphology and microstructure, providing
insights into pore size, the distribution of therapeutic agents, and matrix homogeneity [171]. This information is invaluable for optimizing drug loading, release kinetics, and overall performance. Chemical composition analysis, facilitated by methods
like Fourier Transform Infrared Spectroscopy (FTIR), helps unravel molecular
interactions within the composite [172]. FTIR identies functional groups in the
matrix and drug components, offering insights into potential degradation products
and ensuring compatibility between drugs and polymers. The mechanical properties
of drug-eluting composites, assessed through tensile, compression, and exural
tests, are critical for determining the suitability of these materials for specic applications. For instance, stiffness can inuence drug release kinetics, and understanding these mechanical aspects aids in tailoring the composite for optimal performance.
Overall, a multidimensional characterization approach is essential in elucidating the
intricate features of drug-eluting composites, paving the way for the development of
efcient and tailored drug delivery systems in biomedical applications. Table10.6
shows the advantages and disadvantages of various characterization methods [173].
10.5.1.1 Structural andChemical Analysis
Scanning electron microscopy (SEM) acts as a high-powered zoom lens, revealing
the surface topography and internal architecture of the composite. This detailed
view allows researchers to assess pore size, distribution of therapeutic agents within
the matrix, and overall homogeneity of the material. On the other hand, Fourier
transform infrared spectroscopy (FTIR) shines a light on the chemical landscape.
By identifying functional groups within the matrix and therapeutic agents, FTIR
provides insights into the molecular interactions that govern the composite’s stability and drug release behavior [185].
10.5.1.2 Mechanical Properties
The mechanical integrity of a drug-eluting composite is paramount for its successful function. Tensile, compression, and exural tests subject the material to controlled forces, revealing its strength, stiffness, and elasticity. This information
dictates the suitability of the composite for specic applications, ensuring it can
withstand the physiological demands of the target tissue without compromising
structural integrity or drug release kinetics [186].

10 Composites forDrug-Eluting Devices: Emerging Biomedical Applications
Table 10.6 The advantages and limitations of various characterization techniques [173, 184]
Name of
characterization
techniques Advantages Disadvantages
Scanning electronic
microscopy (SEM)
Transmission electron
microscopy (TEM)
Atomic force
microscopy (AFM)
Magnetic resonance
force microscopy
(MRFM)
X-ray diffraction
(XRD)
It gives a 3D and high-resolution photograph
of nanomaterials.
It gives quick and reliable results.
It provides information on the specimen’s
surface and composition.
It has a resolution power between 1 and
20nm.
It provides incredibly strong magnication
and resolution.
It provides knowledge about elements and
complex structures.
It gives excellent detailed and quality
images. It has a resolution power of
−0.17nm.
It works under liquid, vacuum, and air.
It can be applied to the living system.
It gives sure information about height. It has
a vertical resolution of up to 0.1nm.
It modied the lesion characterization.
No ionization radiation.
It excellently differentiates normal tissues. It
has a vertical resolution of up to 0.1nm.
It is cost-effective and convenient.
Scientists extensively utilize this technique
to nd out the crystalline structure of
nanomaterials.
It is a very effective technique for the
analysis of phases.
These techniques are
very large and
expensive.
Trained people are
required to operate the
SEM.
SEMS can only be used
on solid samples.
The images are black
and white.
It gives black-and-white
photographs .
It requires special
housing and
maintenance.
They are expensive and
large.
It has a limited vertical
and magnication range.
It can break the sample
or tip.
It has a limited scanning
speed.
Required higher
scanning time.
It was highly expensive.
Because of the pulse
generation, it is noisier.
X-rays do not
effectively interact with
lighter elements.
Its intensity is ten times
less than the electron
diffraction.
283
10.5.1.3 Surface Characteristics
Contact angle measurements focus on the wettability of drug-eluting composites,
shedding light on their interaction with biological uids and tissues. Wettability is a
crucial factor inuencing cell adhesion and drug diffusion within the physiological
environment, thereby inuencing the overall biocompatibility of the composite [187].

284
A. K. Gupta et al.
10.5.1.4 Release Kinetics Analysis
High-performance liquid chromatography (HPLC) is employed to quantify released
drugs, offering a detailed understanding of the release rate prole and drug stability
within the composite. Tailoring release kinetics based on therapeutic goals is essential, and HPLC serves as a key method for achieving this customization [188]. To
quantitatively determine the drug loaded in the matrices, the solvents can be
extracted, collected by ltration under efciently designed vacuum chambers [189,
190], and then subjected to HPLC analysis.
10.5.1.5 Biological Compatibility
Cell viability assays assess the cytotoxicity of drug-eluting composites, providing
information on their impact on cell health and the potential for an inammatory
response. Biocompatibility is a critical factor for the long-term success of implants,
making cell viability assays integral to the assessment of these materials [191].
10.5.1.6 In Vivo Imaging andInammatory Response Assessment
In vivo imaging techniques such as MRI and PET allow researchers to study the
distribution and persistence of drug-eluting composites within the body.
Histopathological analysis further assesses tissue compatibility and inammatory
responses, crucial aspects for understanding biomaterial integration and tissue healing around the implant [192].
10.5.1.7 Other Analyses
The other methods for drug stability analysis, swelling and erosion studies, electrochemical analysis, and thermal analysis are also discussed by various researchers
[193–195]. Stability studies inform guidelines on storage and handling while swelling and erosion studies reveal material responses to physiological conditions.
Electrochemical and thermal analyses provide insights into corrosion resistance,
tissue interaction, and thermal stability, ensuring the long-term safety and efcacy
of drug-eluting composite materials. Differential Scanning Calorimetry (DSC) or
Thermogravimetric Analysis (TGA) techniques help evaluate the thermal stability
of drug-eluting composites and provide insights into their response to temperature
changes [183]. By employing these characterization methods, researchers gain a
comprehensive understanding of the structural, chemical, mechanical, and biological properties of drug-eluting composites. This knowledge is crucial for optimizing
the design, fabrication, and performance of these materials in diverse biomedical
applications [196].
Соседние файлы в папке Библиотека им академика М.И. Перельмана
